2024-04-01 2025-03-31 false Capium Accounts Production 1.1 10838305 2024-04-01 2025-03-31 10838305 bus:AbridgedAccounts 2024-04-01 2025-03-31 10838305 bus:FRS102 2024-04-01 2025-03-31 10838305 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10838305 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10838305 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10838305 2024-04-01 2025-03-31 10838305 2025-03-31 10838305 bus:RegisteredOffice 2024-04-01 2025-03-31 10838305 core:WithinOneYear 2025-03-31 10838305 core:AfterOneYear 2025-03-31 10838305 1 2024-04-01 2025-03-31 10838305 bus:Director1 2024-04-01 2025-03-31 10838305 bus:Director1 2025-03-31 10838305 bus:Director1 2023-04-01 2024-03-31 10838305 2023-04-01 10838305 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 10838305 2023-04-01 2024-03-31 10838305 2024-03-31 10838305 core:WithinOneYear 2024-03-31 10838305 core:AfterOneYear 2024-03-31 10838305 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 10838305 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 10838305 bus:OrdinaryShareClass1 2025-03-31 10838305 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 10838305 bus:OrdinaryShareClass1 2024-03-31 10838305 core:FurnitureFittings 2024-04-01 2025-03-31 10838305 core:FurnitureFittings 2025-03-31 10838305 core:FurnitureFittings 2024-03-31 10838305 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 10838305 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 10838305 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 10838305 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 10838305 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 10838305 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 10838305 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 10838305 core:Non-currentFinancialInstruments 2025-03-31 10838305 core:Non-currentFinancialInstruments 2024-03-31 10838305 core:ShareCapital 2025-03-31 10838305 core:ShareCapital 2024-03-31 10838305 core:RetainedEarningsAccumulatedLosses 2025-03-31 10838305 core:RetainedEarningsAccumulatedLosses 2024-03-31 10838305 dpl:Item1 2024-04-01 10838305 dpl:Item1 2025-03-31 10838305 dpl:Item1 2023-04-01 10838305 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10838305
England and Wales

 

 

 

HARRIS PLUS HEALTH LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 515    1,350 
515    1,350 
Current assets      
Cash at bank and in hand 56    71 
Creditors: amount falling due within one year (17,171)   (16,826)
Net current assets (17,115)   (16,755)
 
Total assets less current liabilities (16,600)   (15,405)
Creditors: amount falling due after more than one year (2,413)   (4,481)
Provisions for liabilities (50)   (50)
Net assets (19,063)   (19,936)
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account (19,064)   (19,937)
Shareholders' funds (19,063)   (19,936)
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 December 2025 and were signed by:


-------------------------------
Byron Harris
Director
1
General Information
Harris Plus Health Ltd is a private company, limited by shares, registered in England and Wales, registration number 10838305, registration address 82A, James Carter Road, Mildenhall, Suffolk, IP28 7DE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 25% Straight Line
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 01 April 2024 3,338    3,338 
Additions  
Disposals  
At 31 March 2025 3,338    3,338 
Depreciation
At 01 April 2024 1,988    1,988 
Charge for year 835    835 
On disposals  
At 31 March 2025 2,823    2,823 
Net book values
Closing balance as at 31 March 2025 515    515 
Opening balance as at 01 April 2024 1,350    1,350 


4.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
1 Class A share of £1.00 each  
 

2